What is FLIBAN (FLIBANSERIN)?
The medical drug FLIBAN (FLIBANSERIN) is an innovative pharmacological agent specifically designed for the correction of female sexual dysfunction. This medicinal product belongs to a unique group of drugs acting on the central nervous system, specifically serving as a serotonin antagonist and a dopamine receptor agonist. The primary goal of using this medication is the treatment of hypoactive sexual desire disorder in women in the premenopausal period. It is important to understand that this agent is not a hormonal drug and does not directly affect blood circulation in the genitals, as drugs for men do.
The modern pharmaceutical industry produces FLIBAN (FLIBANSERIN) in a convenient form of film-coated tablets, which protects the active substance from premature destruction in the stomach. The drug is manufactured in compliance with the highest international quality standards, which guarantees its safety and efficacy when used correctly. Each tablet contains a precisely verified dose of the active component, allowing to achieve a stable therapeutic effect during a full course of treatment. Before starting therapy, a consultation with a qualified doctor is mandatory, as self-treatment can lead to undesirable consequences.
The mechanism of action of the drug FLIBAN (FLIBANSERIN) is based on the fine regulation of the balance of neurotransmitters in a woman's brain. It helps to reduce serotonin levels, which often suppress sexual desire, and simultaneously increases the levels of dopamine and norepinephrine, which are responsible for excitement and interest. Thanks to such a complex action at the neurochemical level, natural desire is restored and the level of stress associated with its absence is reduced. It is necessary to keep in mind the individual reaction of the body to any neurotropic agents, so the effectiveness may vary among different patients.
Why is FLIBAN (FLIBANSERIN) prescribed?
The primary and most significant indication for prescribing FLIBAN (FLIBANSERIN) is diagnosed hypoactive sexual desire disorder (HSDD) in women before menopause. This condition is characterized by a persistent or recurrent absence of sexual fantasies and desire for sexual activity, which causes marked personal distress. The drug helps women whose decreased libido is not associated with coexisting medical or psychiatric conditions, relationship problems, or the effects of other medicinal products. The therapy is aimed at restoring the lost interest in intimacy and improving the patient's quality of life.
In addition, FLIBAN (FLIBANSERIN) is prescribed to eliminate the psychological discomfort that arises against the background of sexual dysfunction. Many women experience guilt, anxiety, or frustration due to the lack of natural desire, which can negatively affect their emotional state and partner relationships. Regular intake of the drug helps to reduce these negative emotions by normalizing neurochemical processes in the brain. The restoration of sexual desire occurs gradually, allowing the psyche to gently adapt to positive changes.
It is particularly worth emphasizing the conditions under which FLIBAN (FLIBANSERIN) is not effective and should not be prescribed. This agent is not intended for the treatment of sexual dysfunction in men or for improving sexual performance in women who do not suffer from hypoactive sexual desire disorder. It is also not used by postmenopausal women, as clinical trials for this age group have not confirmed sufficient efficacy and safety. The drug is not an instant-action aphrodisiac, so its use requires patience and strict adherence to medical recommendations.
Composition and active components of FLIBAN (FLIBANSERIN)
The main active substance of the drug FLIBAN (FLIBANSERIN) is the chemical compound of the same name, which has a complex molecular structure and a specific binding profile to brain receptors. It acts as a multifunctional agent modulating the activity of the serotonergic and dopaminergic systems. It is this substance that is responsible for the therapeutic effect, gradually changing the balance of neurotransmitters in the prefrontal cortex of the brain. The concentration of the active component in one tablet is designed to provide optimal action with minimal risk of systemic adverse reactions.
Excipients included in the composition of FLIBAN (FLIBANSERIN) tablets perform an important function of forming, stabilizing, and protecting the active substance. These usually include microcrystalline cellulose, lactose, magnesium stearate, and special polymers that form the film coating. These ingredients ensure the correct release of the drug in the gastrointestinal tract, guaranteeing its complete absorption into the systemic circulation. Patients with known intolerance to lactose or other excipients must inform their doctor about this before starting therapy.
Dosage of FLIBAN (FLIBANSERIN)
The standard recommended dosage of FLIBAN (FLIBANSERIN) for adult women is 100 milligrams once daily. This dose was determined in numerous clinical trials as the most balanced in terms of efficacy and safety. Exceeding the specified dose is strictly prohibited, as it does not lead to an increase in the therapeutic effect but significantly increases the risk of serious adverse events. Dosage adjustment can only be performed by a qualified medical specialist based on individual indicators of the patient's health.
The duration of the treatment course with FLIBAN (FLIBANSERIN) is determined individually, but the first results are evaluated no earlier than after eight weeks of regular use. If after two months of continuous therapy a woman does not feel any improvement in sexual desire or a reduction in associated distress, it is recommended to discontinue the drug. Further use of the agent in case of its ineffectiveness is considered inappropriate and unjustified. Always remember the need for regular consultations with a doctor to monitor your condition during the course.
How to take FLIBAN (FLIBANSERIN) correctly?
To achieve maximum efficacy and minimize side effects, FLIBAN (FLIBANSERIN) should be taken strictly once daily, immediately before bedtime. This dosing regimen is due to the fact that the drug can cause significant drowsiness, decreased blood pressure, and dizziness during hours of peak blood concentration. Taking the tablet in the morning or afternoon hours significantly increases the risk of injury due to possible fainting or impaired coordination of movements. The tablet should be swallowed whole with a sufficient amount of clean water, regardless of food intake.
In case you accidentally missed the evening intake of FLIBAN (FLIBANSERIN), the next dose should be taken at the usual time the following evening. It is categorically forbidden to double the dose or take the medicine in the morning to compensate for the missed dose. This can lead to a sharp drop in blood pressure and the development of a pronounced sedative effect during the active part of the day. Always follow the instructions and recommendations of your treating doctor to make the treatment process as safe and comfortable as possible for your body.
Side effects of FLIBAN (FLIBANSERIN)
Like any medical agent affecting the central nervous system, FLIBAN (FLIBANSERIN) can cause a number of adverse reactions of varying degrees of severity. The most common undesirable events are a feeling of severe fatigue, drowsiness, dizziness, and nausea, which usually occur at the beginning of treatment. In most patients, these symptoms are of a mild or moderate nature and gradually disappear as the body adapts to the drug. However, if these manifestations become too intense or significantly affect the quality of life, it is necessary to seek medical help.
More rare but serious side effects when using FLIBAN (FLIBANSERIN) include pronounced arterial hypotension (severe decrease in blood pressure) and syncope (sudden loss of consciousness). The risk of developing these dangerous conditions increases manifold if the intake regimen is not followed, when consuming alcohol, or when combined with certain other medicinal products. In the event of a pre-fainting state, severe darkening of the eyes, or sudden weakness, one should immediately lie down to avoid injuries from falling. The individual reaction of the body can be unpredictable, so constant monitoring of well-being is mandatory.
Contraindications of FLIBAN (FLIBANSERIN)
The drug FLIBAN (FLIBANSERIN) has a clear list of absolute contraindications, under which its prescription is categorically prohibited. First of all, this agent is contraindicated in women with any hepatic impairment, since the metabolism of the active substance occurs precisely in this organ. A decrease in hepatic clearance can lead to toxic accumulation of the drug in the body and the development of severe complications. The medicine is also not prescribed in the presence of known hypersensitivity to the main component or to any of the excipients included in the tablet.
There are also special groups of patients in whom the use of FLIBAN (FLIBANSERIN) is contraindicated due to the lack of sufficient safety data. This category includes pregnant women and breastfeeding mothers, as the effect of the drug on the development of the fetus and infant remains not fully studied. In addition, the agent is not used in pediatric practice for the treatment of children and adolescents under 18 years of age. Elderly women (over 65 years old) are also usually not prescribed the drug, as the risk of hypotension and fainting in this age group is significantly higher.
Interaction of FLIBAN (FLIBANSERIN) with other medicines and alcohol
The interaction of FLIBAN (FLIBANSERIN) with other pharmacological agents requires special attention and caution from both the doctor and the patient. The agent must categorically not be taken simultaneously with moderate or strong inhibitors of the CYP3A4 enzyme (for example, ketoconazole, itraconazole, certain antibiotics, and antiviral drugs). Such a combination significantly slows down the elimination of the medicine from the body, which can lead to a critical drop in blood pressure. Before starting therapy, it is necessary to provide the doctor with a complete list of all medications, vitamins, and herbal products you are taking.
Particularly strict restrictions apply to the compatibility of FLIBAN (FLIBANSERIN) with any alcoholic beverages. Consuming alcohol during the course of treatment with this drug creates an extremely high risk of developing severe hypotension and sudden loss of consciousness, which can be life-threatening. Patients are strongly advised to completely avoid alcohol for the entire period of therapy. In addition, due to the pronounced sedative effect, driving vehicles and operating complex machinery should be avoided during treatment, at least for the first 6 hours after taking the tablet.
Where to buy FLIBAN (FLIBANSERIN) in Ukraine
As of today, you can buy FLIBAN (FLIBANSERIN) in Ukraine in large pharmacy chains or order it through licensed online pharmacies. Since this drug has a specific mechanism of action and serious risks when used incorrectly, it is dispensed exclusively by a doctor's prescription. Before buying, make sure that you are contacting a reliable pharmacy that has the appropriate quality certificates and complies with the rules of medical product sales. Always check the integrity of the packaging and the expiration date upon receiving your order.
Store FLIBAN (FLIBANSERIN) in its original packaging at room temperature, in a place securely protected from moisture, direct sunlight, and out of reach of children. Do not use the drug after the expiration date indicated on the cardboard box and blister. Remember that the information in this article is provided solely for informational purposes and does not replace professional medical consultation. Be sure to consult with your doctor before starting to take any new medicines to avoid unpredictable reactions of your body.
Free delivery in Ukraine from UAH 1000
Across Ukraine

